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Purpose: The subretinal space, which borders the retinal pigment epithelium (RPE), photoreceptors, and Müller cells, is
an ideal location to deliver genetic vectors, morpholino oligos, and nanopharmaceuticals. Unfortunately, materials injected
into the space tend to stay localized, and degenerative changes secondary to retinal detachment limit its usefulness.
Furthermore, such injection requires penetration of the sclera, RPE/choroid, or the retina itself. Here, we developed a
strategy in Xenopus to utilize the continuity of the brain ventricle and optic vesicle lumen during embryogenesis as a
means to access the subretinal space.
Methods: Wild-type and transgenic embryos expressing green fluorescent protein under the rod-opsin promoter were
used for optic vesicle and brain ventricle injections. For injection directly into the optic vesicle, embryos were laid on one
side in clay troughs. For brain ventricle injections, embryos were placed standing in foxholes cored from agarose dishes.
Linear arrays with each embryo positioned dorsal side toward the micromanipulator facilitated high throughput injections.
Twenty-five micrometer micropipettes, which were positioned with a micromanipulator or by hand, were used to pressure
inject ~1.0 nl of test solution (brilliant blue, India ink, fluorescein isothiocyanate dextran, or 0.04 µm of latex polystyrene
microspheres [FluoSpheres®]). FluroSpheres® were particularly useful in confirming successful injections in living
embryos. Anesthetized embryos and tadpoles were fixed in 4% paraformaldehyde and cryoprotected for frozen sections,
or dehydrated in ethanol and embedded in methacrylate resin compatible with the microspheres.
Results: Direct optic vesicle injections resulted in filling of the brain ventricle, contralateral optic vesicle, and central
canal. Stages 24 and 25 gave the most consistent results. However, even with experience, the success rate was only ~25%.
Targeting the vesicle was even more difficult beyond stage 26 due to the flattening of the lumen. In contrast, brain ventricle
injections were easier to perform and had a ~90% success rate. The most consistent results were obtained in targeting the
diencephalic ventricle, which is located along the midline, and protrudes anteriorly just under the frontal ectoderm and
prosencephalon. An anterior midline approach conveniently accessed the ventricle without disturbing the optic vesicles.
Beyond stage 30, optic vesicle filling did not occur, presumably due to closure of the connection between the ventricular
system and the optic vesicles. Securing the embryos in an upright position in the agarose foxholes allowed convenient
access to the frontal cephalic region. On methacrylate sections, the RPE-neural retina interphase was intact and labeled
with the microspheres. As development continued, no distortion or malformation of the orbital structures was detected.
In green fluorescent protein (GFP), transgenic embryos allowed to develop to stage 41, retinal FluoSpheres® labeling and
photoreceptor  GFP  expression  could  be  observed  through  the  pupil.  On  cryosections,  it  was  found  that  the
FluoSpheres® extended from the diencephalon along the embryonic optic nerve to the ventral subretinal area. GFP
expression was restricted to rod photoreceptors. The microspheres were restricted to the subretinal region, except focally
at the lip of the optic cup, where they were present within the retina; this was presumably due to incomplete formation of
the peripheral zonulae adherens. Embryos showed normal anatomic relationships, and formation of eye and lens appeared
to take place normally with lamination of the retina into its ganglion cell and the inner and outer nuclear layers.
Conclusions: Diencephalic ventricular injection before stage 31 provides an efficient strategy to introduce molecules into
the embryonic Xenopus subretinal space with minimal to the developing eye or retina.
The vertebrate eye arises through a series of reciprocal
inductive interactions between the neuroepithelium, surface
ectoderm,  and  extraocular  mesenchyme.  Central  to  this
choreography is the formation of the optic cup through the
invagination of the optic vesicle. As the vesicle induces lens
formation in the overlying competent surface ectoderm, its
inner layer in turn gives rise to the neural retina, while the
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outer layer becomes the retinal pigment epithelium (RPE). As
this  is  taking  place,  the  optic  stalk  narrows,  eventually
separating the central nervous system (CNS) ventricles and
subretinal space into unique compartments [1,2]. With the
elongation  of  the  outer  segments,  the  interphotoreceptor
matrix (IPM) accumulates within the expanding subretinal
space.  RPE  zonula  occludens  prevent  diffusion  of  matrix
components  sclera;  while  the  zonula  adherens  prevents
molecules  with  a  Stokes’  radius  >30  Å  from  leaving  the
subretinal space vitread between adjacent photoreceptor and
Müller cells [3]. The matrix is thought to mediate RPE/retina
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2956interactions  during  development,  including  adhesion,
sequestration of growth factors, and facilitating the exchange
of retinoids between the RPE and neural retina in the visual
cycle [4-8].
Because it borders the RPE, photoreceptors, and Müller
cells, the subretinal space is an ideal location for delivering
molecules to the outer retina. Subretinal injection can be easily
performed  in  rodents  [9-11],  and  has  been  useful  for  the
introduction of viral vectors [12-14] and growth factors into
the retina [15-18]. Many of these studies have been extended
into clinical trials, further establishing the usefulness of the
subretinal space in gene delivery [13,19-21].
Although  the  IPM  is  an  ideal  location  to  deliver
molecules to the retina, several factors limit the usefulness of
subretinal  injections.  In  theory,  material  injected  into  the
subretinal space should have access to the entire matrix, and
therefore all of the RPE, photoreceptors, and Müller cells.
However,  injected  material  tends  to  stay  localized  at  the
injection  site  [9,10].  Furthermore,  pathological  changes
secondary to the injection itself are not uncommon, as the
method requires penetration of the sclera and RPE/choroid, or
the retina itself. Finally, retinal detachment, an unavoidable
consequence of subretinal injection, can alter ocular gene
expression, and result in retinal and RPE degeneration [22,
23].
A method allowing the less traumatic introduction of
molecules into the subretinal space would be very useful for
basic  and  translational  research.  In  particular,  Xenopus,  a
favorite  of  the  experimental  embryologist,  develops
exogenously, can be manipulated surgically, and is amendable
for transgenic strategies. However, the inability to deliver test
compounds to the retina and subretinal space remains a major
obstacle. For example, it would be useful to be able to deliver
DNA constructs, morpholino oligos, and morphogens into the
subretinal space to study photoreceptor gene expression and
function. Currently, morpholinos are commonly introduced
into the embryo by blastula injection. However, when injected
in  this  way,  the  morpholino  is  diluted  out  during
organogenesis, limiting its ability to inhibit mRNA translation
at late stages such as those needed to study photoreceptor
development and function.
To circumvent a direct injection approach, we wanted to
develop a less invasive strategy to deliver molecules to the
subretinal  space  without  disruption  of  the  retina.  Such  a
method  should  not  disturb  the  retina  anatomically.  We
considered that the normal developmental sequence of the
CNS and ocular structures could provide an opportunity to
accomplish this goal. Figure 1 illustrates the lumen of the optic
vesicle is continuous with that of the brain ventricle early in
development [24]. We anticipated that material introduced
into  the  optic  vesicle  or  brain  ventricle  would  become
sequestered within the subretinal space as the eye forms. Our
studies  suggest  that  optic  vesicle  or  brain  ventricle
microinjection provides a nondisruptive strategy to deliver
molecules into the subretinal space.
METHODS
This research was performed under protocols approved by the
Veterans Affairs Medical Center Institutional Animal Care
Figure 1. The relationship between the
optic vesicle and brain ventricles in the
developing Xenopus embryo are shown
in these diagrams. The cross-sections,
which  are  through  the  optic  vesicles
(dashed lines), compare stages 23, 26,
and  27  in  A,  B,  and  C  respectively.
These drawings, were prepared based on
[24,30],  to  illustrate  that  the  brain
ventricle and optic vesicle lumens are
continuous at least at stage 23.
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2958and Use Committee. Adult pigmented Xenopus laevis were
obtained  from  Xenopus  1  (Dexter,  MI)  or  NASCO  (Fort
Atkinson, WI). Animals were maintained under a 12 h:12 h
light-dark  cycle  in  an  XR1  aquarium  system  (Aquatic
Habitats,  Apopka,  FL).  Lines  of  transgenic  animals
expressing GFP under the rod-opsin promoter [25] were used
in  some  experiments  to  identify  the  developing
photoreceptors. These animals were generated by restriction
enzyme  mediated  integration  [26,27],  using  linearized
plasmid pXO-GFP generously provided by Dr. Barry Knox
(SUNY, Syracuse, NY) [28]. Methods for embryo care and
Xenopus husbandry were followed as previously described
[29].  Embryos  were  staged  according  to  Nieuwkoop  and
Faber [30]. The following describes embryo handling, the
subretinal  delivery  method,  and  useful  photography  and
histological notes.
Embryo  preparation:  Embryos  for  injection  can  be
obtained either by natural or in vitro fertilization. Although
the latter has the advantage of generating embryos at nearly
identical developmental stages, natural fertilization is often
convenient, especially when different stages are desired. The
preference therefore largely lies in what is routinely available
in the laboratory. For either method, it is helpful to maintain
groups  of  developing  embryos  at  various  temperatures
ranging from 14 to 22 °C. This lengthens the time window
when the desired stages are available. Khokha et al. [31]
provides  charts  of  the  effect  of  temperature  on  Xenopus
laevis and Xenopus tropicalis development (see also Xenopus
development).
Embryos are secured for microinjections in modeling
clay or agarose dishes, and for most routine work, visualized
under Stemi 2000 stereomicroscopes equipped with zoom
magnification (Carl Zeiss, Germany). Although embryos at
the  developmental  stages  used  for  injection  are  not  free
swimming,  spontaneous  movements  can  interfere  with
securing the animals and performing injections. Benzocaine
(Sigma; St Louis, MO), at a final concentration of 0.005 to
0.01%,  is  effective  in  eliminating  such  movements  (see
comments  under  troubleshooting  guide,  Table  1).  For
injections directly into the optic vesicle, the embryo is laid on
its side in a trough formed in modeling clay. Having tried
several  types  of  modeling  clay,  we  found  that  the  blue
nonhardening/nontoxic type such as that from Sargent Art
(Hazleton, PA) has the right malleability without any apparent
toxicity to the embryos. The embryo is positioned in the clay
as described below, and a flap of clay gently brought over to
secure it in place.
For brain ventricle injection, we found it was best to
orient the embryo in a vertical “standing position” in 1%
agarose (BioRad; Hercules, CA) dishes as shown in Figure 2.
We adapted a method previously described to orient zebrafish
embryos for brain ventricle injections [32]. In adapting the
method for Xenopus, we considered that the overall length of
a stage 28 embryo is approximately 4 mm. For 60×15 mm
plastic Petri dishes with a base diameter of 5.0 cm, 6.9 ml of
agarose gives a thickness of ~3.5 mm allowing the head to
protrude slightly out of the foxhole. The holes are punched
out under water using a Pasteur pipette broken 1.0 cm from
Figure  2.  This  diagram  illustrates  the
position of embryos in agarose dishes
for brain ventricle injections. Embryos
were placed in foxhole arrays punched
out of 1% agarose dishes (blue). At least
25 foxholes can be prepared per dish.
The holes are made to a depth so that the
head  protrudes  slightly  out  of  the
foxhole (see Methods). The embryonic
diencephalic ventricle is located along
the  midline,  and  protrudes  anteriorly
just  under  the  frontal  ectoderm  and
prosencephalon  (compare  with  Figure
3).  A  midline  anterior  approach
conveniently  accesses  the  ventricle
without  disturbing  the  optic  vesicles
(middle embryo). The injected material
(pink) readily fills the brain ventricle
with optic vesicle, and typically can be
appreciated extending into the central
canal [30].
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2959its tip (5 3/4” flint glass, Cat#13–678–6A; Fisher). This gives
a final hole diameter of ~1.25 mm, which accommodates the
embryo well. It is best to arrange the holes in linear arrays,
and position each embryo with the dorsal side toward the
micromanipulator.  This  facilitates  performing  numerous
injections and keeping track of the injected embryos.
A generally useful trick for gently positioning embryos
without directly handling them is to make use of their cement
gland, an anterior-ventral pigmented structure. Embryos use
this mucin-secreting organ to attach to stationary supports
before being able to swim. The cement gland also appears to
have a sensory function, stopping the embryo from moving
once attached [33]. Embryos will stick to the forceps tip at the
cement  gland,  and  can  then  be  dragged  up  and  over  the
foxholes. The embryo is then pushed backward into the hole
while guiding the tail end downward with a second forceps.
Subretinal delivery methods: Subretinal delivery can be
accomplished  by  direct  optic  vesicle  or  brain  ventricle
injection.  Securing  the  embryos  for  injection  using  either
method  is  described  above.  For  optic  vesicle  injection,
embryos were tilted 30° to one side in clay dishes; for brain
ventricle injections, the embryos were positioned vertically in
agarose dish foxholes (Figure 2 and Figure 3). For both types
of injection, glass micropipettes (1BBL no fill 1.0mm 4 in.
cat# 1B100–4; World Precision Instruments, Sarasota, FL)
were prepared on a micropipette puller. Tips were carefully
broken by hand using jeweler’s forceps to a 20 to 30 µm outer
diameter. The micropipettes were positioned with a Manual
LH  mechanical  micromanipulator  (Harvard  Apparatus;
Holliston,  MA).  We  found  that  particularly  for  the  brain
ventricle  injections,  the  micropipette  could  be  positioned
equally well by hand. This was more efficient when injecting
numerous  embryos  (>25  embryos  per  dish).  A  PLI-100
Figure 3. Horizontal section of a stage
26  embryo  illustrating  the  brain
ventricle  injection  method  used  to
introduce materials into the optic vesicle
lumen.  A:  A  glass  micropipette  was
introduced  into  the  diencephalic
ventricle anteriorly. B: The dashed line
shows the orientation of the section in
panel A. The drawings were prepared
based on [24,30].
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2960microinjection  system  (Harvard  Apparatus)  was  used  to
pressure inject approximately 10.0 nl of test solution to either
the  optic  vesicle  or  brain  ventricle.  Typically,  pressure
injection  per  se  was  not  necessary,  and  filling  was
accomplished simply by the system’s backpressure. Diluted
blue food coloring (brilliant blue) was useful to help visualize
the injection. The injected dye can be visualized accumulating
in  the  optic  vesicle  lumen  or  brain  ventricle  under  the
ectoderm. In the last injection series of the included movie
(Figure 4), the darkening of the optic vesicle represents such
filling.  Extension  into  the  neural  canal  could  often  be
observed. Materials injected included India ink, fluorescein
isothiocyanate (FITC) dextran, and fluorescent 0.04 µm latex-
polystyrene microspheres (FluoSpheres®, Life Technologies,
Carslbad,  CA).  Cy3-FluoSpheres®  were  used  to  visualize
injections  into  living  embryos  using  a  Stemi  SV  11
epifluorescence microscope with an HBO103 mercury lamp
and  29004  ET-Cy3  filter  cube  (ET545/25×,  T565lpxr,
ET605/70m; Chroma, Bellows Fall, VT). In contrast to the
developing mammalian retina, Xenopus embryonic tissues,
including  the  retina,  contain  autofluorescent  cytoplasmic
yoke  granules.  Cy3  and  FITC  dyes  were  selected  for  the
injection markers, as they could be clearly distinguished from
the tissue autofluorescence while allowing the possibility of
using additional fluorochromes emitting further in the red for
immunofluorescence double labeling. The reader is referred
to additional helpful published protocols on the subject [34,
35].
Histology  and  microscopy:  For  imaging  the
FluoSpheres®  injection  in  vivo,  living  embryos  were
visualized  with  a  Zeiss  Stemi  11  fluorescence
stereomicroscope. For histological evaluation, anesthetized
embryos and tadpoles were fixed in 4% paraformaldehyde and
cryoprotected through graded sucrose solutions (final, 20%
sucrose),  followed  by  infiltration  with  Optimal  Cutting
Temperature compound (Ted Pella, Redding, CA; see notes
in Table 1). Alternatively, fixed embryos were dehydrated in
ethanol and embedded in Lowicryl resin according to the
manufacturer (London Resin Co.). Lowicryl sections have
excellent  morphological  detail,  and  being  a  methacrylate-
based  hydrophilic  resin,  Lowicryl  is  compatible  with  the
latex-polystyrene FluoSpheres®. Confocal microscopy was
performed  on  an  Axiovert  200  motorized  microscope
equipped with a Zeiss LSM 510 system (laser lines: GFP, ex
477 nm; Cy3, ex 565 nm). The multiphoton capability used to
visualize  4',6-diamidino-2-phenylindole  (DAPI)  was
provided through a Coherent Chameleon Ultra II laser. Data
collection  and  image  analysis  were  performed  with  LSM
software version 4.2, and figures created in Adobe Creative
Suite version 4.0 (San Jose, CA).
RESULTS
We compared the effect of embryonic stage and injection
route on the ability to target the subretinal space. In our initial
experiments, we injected the optic vesicle directly at stages
24 through 26. The most consistent fills were obtained at
stages 24 and 25, where the optic vesicle lumen appears to be
at its largest volume. Targeting the vesicle is more difficult
beyond stage 26 due to flattening of the lumen. We positioned
the micropipette on the transverse plane near the apex of the
protruding vesicle. Filling of the injected vesicle with FITC
dextran was almost immediate, followed by the brain ventricle
and contralateral optic vesicle (Figure 5). After one to two
minutes,  the  label  diffused  into  the  central  canal  (white
asterisk). Compared to dextran, the fluorescent microspheres
showed less rapid canal diffusion, but readily filled the optic
vesicles and brain ventricle (see below).
Figure 4. Xenopus subretinal delivery
strategy.  Animation  1.  The  attached
movie  illustrates  the  diencephalic
injection  strategy  to  introduce
microspheres into the optic vesicle of
Xenopus laevis embryos. Note that the
slide bar at the bottom of the quicktime
movie can be used to manually control
the flow of the movie. If you are unable
to  view  the  movie,  a  representative
frame is included.
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2961Our second strategy took advantage of the continuity of
the brain ventricle with the lumen of the embryonic optic
vesicle. Although the ventricle lumen is accessible from a
variety of injection angles, we found that an anterior midline
approach gave the most consistent fills. As shown in Figure
3A, the embryonic diencephalic ventricle is located along the
midline,  and  protrudes  anteriorly  just  under  the  frontal
ectoderm. A midline anterior approach conveniently accesses
the ventricle without disturbing the optic vesicles. Securing
the embryos in an upright vertical position in agarose dishes
allowed convenient access to the frontal cephalic region, and
facilitated the injection of multiple embryos (Figure 2).
We  anticipated  that  material  introduced  into  the
diencephalic ventricle would diffuse into the optic vesicles
bilaterally; vesicle involution would sequester the material
into  embryonic  subretinal  space.  The  distribution  of
fluorescent microspheres after stage 26 injections are shown
in a living embryo (Figure 6) ~15 min after the injection, and
histologically  (Figure  7)  following  optic  cup  formation
(~stage 28). Figure 6A,C shows dorsal and lateral views,
respectively, illustrating the optic vesicles, which normally
appear  to  bulge  from  the  head  laterally  (slanted  arrows).
Viewed dorsally under fluorescence, filling of both vesicles
can be seen; accordingly, when viewed laterally, filling of the
diencephalic ventricle can also be observed (vertical arrow).
In Figure 7, formation of the optic cup is complete, and the
outer  layer  of  the  cup  has  become  pigmented,  which  is
indicative of RPE differentiation (Figure 7A). The outer retina
shows  little  evidence  of  differentiation  such  as  retinal
lamination or outer segment formation. The tissue in this
photomicrograph  was  embedded  in  methacrylate,  a
hydrophilic  resin,  which  provides  higher  resolution  than
paraffin  or  frozen  sections,  and  is  compatible  with  the
FluoSpheres® (organic solvents such as xylenes required for
wax  infiltration  compromise  the  integrity  of  the
microspheres). When viewed under fluorescence (Figure 7B),
microspheres injected in the contralateral vesicle are found
distributed  at  the  interphase  between  the  RPE  and  neural
retina.  Whether  the  microspheres  are  present  in  the
interphotoreceptor  matrix  or  in  the  cytoplasm  of  cells
bordering the subretinal space cannot be determined from this
photomicrograph. As the embryo continues to develop into a
free-swimming tadpole, we do not detect any distortion or
malformation of the orbital structures (Figure 8A), and retinal
labeling appears as fluorescence emanating through the pupil
(arrow in Figure 8B). These findings support the conclusion
that subretinal access via brain ventricle injection or injection
of the contralateral optic vesicle does not disturb the normal
formation of the ocular structures, nor does it prevent the
normal involution of the vesicle and apposition of the RPE
with the neural retina.
Figure  5.  Optic  vesicle  fluorescein
isothiocyanate–dextran  injection.  The
injection was performed at stage 24, and
photographed  here  at  stage  28.  A:
Fluorescence shows filling of the optic
vesicle (arrow), brain ventricle (black
asterisk),  and  central  canal  (white
asterisk).  B:  This  illustration  was
prepared to be consistent with stage 28
as in reference [30].
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2962Access to the optic vesicle via the brain ventricle was
dependent  on  the  embryonic  stage.  Figure  9  compares
embryos at stages 29 and 31 photographed immediately after
injection. Here, diencephalic ventricular injection supported
optic vesicle filling at stage 29, but not at stage 31 (Figure 9B).
The two embryos in Figure 10 were injected either at stage 24
or 31, and allowed to mature to swimming tadpoles. Although
the eyes of both tadpoles developed normally, fluorescence
was detected only in the tadpole injected at stage 24. These
results suggest that the connection between the brain ventricle
and optic vesicle closes beyond stage 30.
In Figure 11, the diencephalic ventricle of a GFP-rod
opsin transgenic embryo was injected through the anterior
prosencephalon at stage 29. The embryo was then allowed to
develop  to  stage  41.  As  in  other  embryos  receiving  such
injections, the external appearance of the eye and pupil were
unaffected (Figure 11A-C). FluoSphere® labeling of the retina
and photoreceptor GFP expression could be observed through
the pupil. The cryosection shown in Figure 11D,E uses DAPI
as  a  fluorescent  nuclear  counterstain.  GFP  expression  is
restricted to rod photoreceptors, which are still undergoing
outer  segment  elongation  (arrowheads,  Figure  11E).  The
FluoSpheres®  labeled  the  entire  diencephalon  (asterisk,
Figure  11D),  presumably  by  direct  diffusion  from  the
ventricle lumen. In Figure 11D, the microspheres extend from
the diencephalon to the eye along the embryonic optic nerve
(arrowhead, Figure 11D). Higher magnification shows the
FluoSpheres®  in  the  ventral  subretinal  area  (Figure  11E).
Figure  6.  Cy3  microspheres  were
injected into the diencephalic ventricle
at stage 26. Panels A, B and C, D are
dorsal and lateral views, respectively, of
the  same  embryo  showing  the  optic
vesicles,  which  normally  appear  to
bulge laterally from the head (slanted
arrows). Under fluorescence, the optic
vesicles  are  filled  with  FluoSpheres®
(panels  B,  D).  The  vertical  arrow  in
panels C, D indicates the diencephalic
ventricle  which  also  contains  the
FluoSpheres®. The scale bar in the lower
right equals 0.5 mm.
Figure 7. Texas red microsphere were delivered to retinal pigment epithelium/retina interface. The contralateral optic vesicle was injected
with the microspheres at stage 26. A: At stage 28, the embryo was embedded in methacrylate polymer. At this stage, formation of the optic
cup is complete and melanin pigment is visible in the retinal pigment epithelium. B: The same section photographed under fluorescence shows
the microspheres appearing as red dots (arrows) along the RPE/retina interface.
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2963Peripherally, the microspheres are focally present within the
outer and inner nuclear layers (arrows, Figure 11E). Overall,
the  embryo  shows  normal  anatomic  relationships  of  the
diencephalon, eye, and gastrointestinal lumen. Furthermore,
formation of the eye and lens appears to have taken place
normally with lamination of the retina into its ganglion cell,
and inner and outer nuclear layers. The above findings are
consistent with the developmental stage, and suggest that the
procedure does not significantly affect the formation of the
eye and retina.
DISCUSSION
Direct access to the subretinal space in vivo is problematic
due to the consequences of retinal detachment. However, in
vitro systems do not always adequately model the complex
interactions between the RPE, interphotoreceptor matrix, and
neural retina. The motivation for the present study was to
develop a strategy to introduce molecules into the subretinal
space without disturbing the relationship between the RPE
and neural retina. We reasoned that material injected into the
common embryonic CNS lumen would diffuse to both optic
vesicles. Subsequent involution of the vesicles would bring
the material into the subretinal space of the optic cups. A
particular  advantage  of  this  method  is  that  the  injected
material has access to the entire RPE, photoreceptor layer, and
Müller cell glia. In contrast, subretinal injections as typically
performed generally allow access only to a limited portion of
the  interphotoreceptor  matrix  [9].  Previous  studies  in
Xenopus  using  intraretinal  injection  and  electroporation
achieved only focal labeling of the retina [36]. Although the
overall strategy is feasible, advantages and limitations of the
method are presented so that it can be tailored for different
experimental paradigms. With a little practice, the injections
can  be  performed  routinely  even  by  those  with  little
Xenopus experience.
We  began  by  attempting  to  inject  the  optic  vesicles
directly.  Direct  injection  into  the  optic  vesicle  could  be
advantageous when the opposite retina is needed as a control,
or when brain injection is not desirable (for example, in optic
nerve  tracking  studies).  However,  although  it  can  be  an
effective way to deliver to the subretinal space of both retinas,
the  success  rate  was  low  (~25%)  even  with  experience.
Furthermore, one of the eyes was unavoidably subjected to
the  trauma  of  the  injection  itself.  The  main  problem  was
accurately accessing the appropriate depth of penetration for
the micropipette. It should be kept in mind that the vesicle
lumen at most stages is a compressed flattened chamber, and
therefore difficult to hit (note that the lateral protrusions of the
optic  vesicle  are  mainly  due  to  the  thickening  of  the
developing inner neural retina). Ohnuma et al. [37] reported
Figure 8. FluoSphere® labeling in the tadpole eye. Four days prior, this living, free-swimming tadpole received a Cy3-FluoSpheres® brain
ventricle injection at stage 26. A: Macroscopically, there is no apparent distortion or malformation of the orbital structures. B: Under
fluorescence, the label is restricted to the brain and retina. In the eye, the fluorescence emanates through the pupil (arrow). Although the right
eye was equally labeled, its fluorescence is not visible, as its pupil is not in view.
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2964some experience using direct optic vesicle microinjections to
transfect plasmid constructs in Xenopus laevis. Using stage 24
embryos,  they  found  that  the  transfection  efficiency  for
injections made “outside” the vesicle (lumen region) was only
half that of injections made “inside” (between the neural retina
and  ectoderm).  It  is  not  known  whether  this  regional
difference  reflects  a  biologic  difference,  or  difficulties  in
targeting the optic vesicle lumen. Brain ventricle injection as
an avenue to deliver material to the optic vesicles was not
attempted in that study, or in any other study that we are aware
of in the literature.
Brain  ventricle  injection  had  several  advantages  over
direct optic vesicle injection. The most significant was that
the diencephalic ventricle has a larger volume compared to
that of the optic vesicle. This allows it to accept injections
along  a  wider  range  of  micropipette  penetration  depths.
Ninety  percent  or  more  of  the  injections  are  successful.
Furthermore, brain ventricle injection avoids subjecting an
eye to the trauma of the injection. Using the brain ventricular
injection,  we  have  not  observed  any  abnormality  in  the
development  of  the  ocular  structures.  The  pupil,  rate  and
extent  of  pigmentation,  external  appearance  of  the  globe,
histological lamination of the retina, and rod photoreceptor
differentiation  all  appear  to  be  indistinguishable  from
controls. Finally, the brain ventricle method lends itself well
to  a  higher  throughput  compare  to  direct  optic  vesicle
Figure  9.  Cy3-FluoSpheres®  were
injectedbefore, and after separation of
the optic vesicle lumen from the brain
ventricular system. These photographs
were taken 10 min after injection into
the diencephalic ventricle. A: The older
stage  31  (upper)  embryo  has  a  more
advanced overall body shape, with fuller
development of its tail bud (*) compared
to the stage 29 embryo beneath it. The
arrows  show  the  optic  vesicles.  B:
Under  fluorescence,  although  brain
ventricle  labeling  is  seen  in  both
embryos,  optic  vesicle  filling  is  seen
only in the stage 29 embryo (arrows).
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2965injections. Here, the use of agarose dish foxholes facilitates
orienting  numerous  embryos  for  injection.  Hundreds  of
embryos can be injected in a single morning. Finally, it should
be  pointed  out  that  any  experimental  paradigm  using  the
diencephalic ventricle injection or the direct optic vesicle
route should include appropriate experimental controls. Such
controls would be critical to distinguishing a genuine biologic
phenotype from nonspecific effects of the injection, carrier,
and/or the test molecule itself.
Several  issues  should  be  considered  when  planning
experiments  using  the  delivery  method  described  here.  A
potential limitation of the method is that delivery may not be
uniform  throughout  the  subretinal  compartment  for  all
developmental stages. In the brain ventricle injection shown
in Figure 11, labeling was restricted to the dorsal retinal space.
This may represent a positional effect due to gravity, or a
regional difference in the accessibility of the subretinal space.
It should be pointed out that confinement of any material
introduced into the subretinal space will depend on a variety
of factors, including the rate at which the material leaves the
space.  Turnover  of  molecules  introduced  into  the
interphotoreceptor matrix could depend on the integrity of the
external limiting membrane and the size of the molecule. The
exclusion limit of the zonulae adherens in rabbits is between
30Å and 36Å [3]. For example, interphotoreceptor retinoid-
binding  protein  (140  kDa),  a  normal  component  of  the
interphotoreceptor matrix, exceeds this exclusion limit, and is
therefore  confined  to  the  subretinal  space  where  it
accumulates [4]. However, smaller molecules would not be
excluded, and therefore should diffuse into the retina (this may
be desired depending on the experimental objectives). The
labeling of the peripheral retina (Figure 11E) may be due to
incomplete formation of the zonulae adherens in this less-
developed  region  of  the  retina.  Thus,  confinement  to  the
subretinal space may be dependent on the stage at which the
injection is performed. Ongoing experiments in our laboratory
are addressing the above issues.
Brain ventricle injection as a way to deliver molecules or
microspheres to the subretinal space can be applied only when
the optic vesicle lumen is continuous with the CNS ventricular
space. There is little information in the literature about the
timing of the closure of the passageway. Detailed published
anatomic  drawings  suggest  that  the  passage  between  the
compartments is lost from stage 26 onward [24]. In contrast,
we found that FluoSpheres® can diffuse from the diencephalic
ventricle to the optic vesicle through stages 29/30. From stage
Figure 10. Retina access is dependent on the embryonic stage. The diencephalic ventricles were injected at stage 24 (A, B) or stage 31 (C,
D), and the embryos allowed to mature to swimming tadpoles. The eyes of both tadpoles appear to have developed normally. Cy3 fluorescence,
which is appreciated through the pupil (arrow), is present only in the stage 24 injected tadpole. Such retinal labeling can be achieved through
stage 29/30. For stages 31 and older, brain ventricle injection does not support delivery to the retina.
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296631 onward, the connection between the brain ventricle and
subretinal compartment does not allow passage of the 0.04 µm
microspheres. This does not rule out that the passage is patent
to materials < 0.04 µm in diameter.
The subretinal delivery strategy described here may be
applicable to some other systems where the subretinal space
forms through the involution of the optic vesicle. In its present
form,  the  method  could  probably  not  be  applied  to  most
invertebrates due to the absence of a common shared chamber
similar  to  the  vertebrate  subretinal  space.  Although  our
experience to date is limited to Xenopus laevis, given the
similarity of their retinas, the method should be applicable to
Xenopus tropicalis. The fact that development occurs in the
extrauterine  environment  is  an  obvious  advantage  of
amphibians over rodents for this method. Subretinal delivery
via brain ventricle injection can probably be applied to other
vertebrates such as avian embryos where access to the brain
ventricle  is  feasible.  A  strategy  has  been  described  for
injection into the brain ventricular system of zebrafish [32,
38]; however, to our knowledge, brain ventricle injection has
Figure 11. Diencephalic ventricular injection was used to deliver Cy3-FluoSpheres® to the retina of transgenic tadpoles expressing green
fluorescent protein under the rod-opsin promoter. The brain ventricle was injected through the anterior prosencephalon at embryonic stage
27, and development allowed to continue for 48 h to stage 41. A: In vivo photograph showing the normal external appearance of the eye and
pupil (arrow). B: Cy3-FluoSphere® labeling of the retina can be viewed through the pupil. C: Retinal expression of green fluorescent protein
(GFP) is apparent through the pupil. D: Cryosection (transverse plane) through the eye at the level of the optic nerve (arrowhead) shows that
the Cy3-FluoSpheres® have diffusely labeled the diencephalon (asterisk), and are found extending through the optic nerve to the subretinal
region. E: This higher magnification of boxed area in panel D shows GCL, ganglion cell layer; inner nuclear layer, ONL, outer nuclear layer;
OS, outer segments; RPE, retinal pigmented epithelium; Arrowheads, rod photoreceptors expressing GFP.
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2967not been performed at the early developmental stages where
labeling of the retina might be expected. Nevertheless, the
utility of the method in this species may be limited, as the
zebrafish optic cup does not appear to form from a typical
optic vesicle involution sequence as in other vertebrates [39].
In summary, the technique described here provides a
strategy  to  introduce  molecules  into  the  subretinal  space
without disturbing eye development. The approach, which
takes advantage of the common lumen between the brain
ventricle and optic vesicles during development, may provide
a practical approach to routinely deliver molecules to the
subretinal  space  without  disturbing  the  normal  anatomic
relationships between the RPE and retina. This could allow
the  introduction  of  molecules,  including  tagged  proteins,
antibodies,  DNA  constructs  and  morpholino
oligonucleotides, for cellular and genetic manipulations. The
method  can  probably  be  adapted  to  other  experimental
systems  where  the  optic  vesicle  and/or  embryonic  brain
ventricle can be accessed.
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